Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osteotech gets US nod for spinal GraftCage interbody devices:

This article was originally published in Clinica

Executive Summary

The US FDA has given Osteotech the all-clear to sell its GraftCage ACX product for replacing a collapsed, damaged, or unstable vertebral body in the thoracic or lumbar spine. The device, which restores the height of a collapsed vertebral body, features titanium markers to facilitate intra-operative and post-operative radiographic assessments. It also has an opening for the insertion of bone grafting materials, including a new form of the firm's recently introduced Xpanse bone insert, to allow for maximum graft exposure. GraftCage is scheduled for launch in the first quarter of 2006.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058207

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel